ArticleAntimicrobial agents and chemotherapy2010

Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.

Yasushi Tojo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.